Whole-body distribution of tenofovir, emtricitabine and dolutegravir in non-human primates.
Thibaut GeléHélène GougetNastasia DimantValérie FurlanJon CollinsErin M B ScholzChris M ParryRoger Le GrandOlivier LambotteDelphine DesjardinsAurélie Barrail-TranPublished in: The Journal of antimicrobial chemotherapy (2024)
Overall, this study determines the first whole-body distribution in a validated NHP model. These data have important implications for future preclinical and clinical studies for the development of novel HIV therapies towards an HIV cure.